Back to Search
Start Over
Vasodilation and Antihypertensive Activities of Swietenia macrophylla (Mahogany) Seed Extract.
- Source :
-
Journal of medicinal food [J Med Food] 2018 Mar; Vol. 21 (3), pp. 289-301. Date of Electronic Publication: 2018 Feb 08. - Publication Year :
- 2018
-
Abstract
- The seeds of Swietenia macrophylla King (SM) (Meliaceae) are used as a folk medicine for the treatment of hypertension in Malaysia. However, the antihypertensive and vasorelaxant effects of SM seeds are still not widely studied. Thus, this study was designed to investigate the in vivo antihypertensive effects and in vitro mechanism of vasorelaxation of a 50% ethanolic SM seed extract (SM50) and the fingerprint of SM50 was developed through tri-step Fourier transform infrared (FTIR) spectroscopy. The vasorelaxant activity and the underlying mechanisms of SM50 were evaluated on thoracic aortic rings isolated from Sprague-Dawley rats in the presence of antagonists. The pharmacological effect of SM50 was investigated by oral administration of spontaneously hypertensive rats (SHRs) with three different doses of SM50 (1000, 500, and 250 mg/kg/day) for 4 weeks and their systolic blood pressure (SBP) and diastolic blood pressure (DBP) values were measured weekly using tail-cuff method. The tri-step FTIR macro-fingerprint of SM50 showed that SM50 contains stachyose, flavonoids, limonoids, and ester, which may contribute to its vasorelaxant effect. The results showed that the vasorelaxant activity of SM50 was mostly attributed to channel-linked receptors pathways through the blockage of voltage-operated calcium channels (VOCC). SM50 also acts as both potassium channels opener and inositol triphosphate receptor (IP <subscript>3</subscript> R) inhibitor, followed by β <subscript>2</subscript> -adrenergic pathway, and ultimately mediated through the nitric oxide/soluble guanylyl cyclase/cyclic 3',5'-guanosine monophosphate (NO/sGC/cGMP) signaling pathways. The treatment of SM50 also significantly decreased the SBP and DBP in SHRs. In conclusion, the antihypertensive mechanism of SM50 was mediated by VOCC, K <superscript>+</superscript> channels, IP <subscript>3</subscript> R, G-protein-coupled β <subscript>2</subscript> -adrenergic receptor, and followed by NO/sGC/cGMP signaling mechanism pathways in descending order. The data suggested that SM50 has the potential to be used as a herbal medicament to treat hypertension.
- Subjects :
- Animals
Antihypertensive Agents administration & dosage
Antihypertensive Agents chemistry
Antihypertensive Agents pharmacology
Aorta, Thoracic
Calcium Channel Blockers administration & dosage
Calcium Channel Blockers chemistry
Calcium Channel Blockers pharmacology
Calcium Channel Blockers therapeutic use
Dose-Response Relationship, Drug
Endothelium, Vascular drug effects
Endothelium, Vascular physiology
Endothelium, Vascular physiopathology
Ethnopharmacology
Hypertension metabolism
Hypertension physiopathology
In Vitro Techniques
Malaysia
Male
Medicine, Traditional
Muscle, Smooth, Vascular drug effects
Muscle, Smooth, Vascular physiology
Muscle, Smooth, Vascular physiopathology
Plant Extracts administration & dosage
Plant Extracts chemistry
Plant Extracts pharmacology
Rats, Inbred SHR
Rats, Sprague-Dawley
Spectroscopy, Fourier Transform Infrared
Vasoconstriction drug effects
Vasodilation drug effects
Vasodilator Agents administration & dosage
Vasodilator Agents chemistry
Vasodilator Agents pharmacology
Antihypertensive Agents therapeutic use
Hypertension drug therapy
Meliaceae chemistry
Plant Extracts therapeutic use
Seeds chemistry
Vasodilator Agents therapeutic use
Subjects
Details
- Language :
- English
- ISSN :
- 1557-7600
- Volume :
- 21
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Journal of medicinal food
- Publication Type :
- Academic Journal
- Accession number :
- 29420109
- Full Text :
- https://doi.org/10.1089/jmf.2017.4008